Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--letter

Clin Cancer Res. 2013 Oct 1;19(19):5541. doi: 10.1158/1078-0432.CCR-13-1054. Epub 2013 Sep 18.

Authors

Laszlo Radvanyi¹, Shari Pilon-Thomas, Weiyi Peng, Amod Sarnaik, James J Mulé, Jeffrey Weber, Patrick Hwu

Affiliation

¹ Authors' Affiliations: Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas; and Cutaneous Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
B7-H1 Antigen / antagonists & inhibitors*
Humans
Neoplasms / therapy*
Programmed Cell Death 1 Receptor / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
B7-H1 Antigen
Programmed Cell Death 1 Receptor

Grants and funding